← All stocks

ANAPTYSBIO, INC

ANAB Net buying
CIK 0001370053 #2173 in the set updated 19 Sep 2026
Bought (120 mo)
$116.61M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$81.35M
$463.54K on a plan · $27.71M straight out of an exercise
Sold at will
$53.18M
66 of 140 sales
Net
+$35.25M
+$63.43M against sales at will

By person

22 insiders · 179 transactions
40.3×

Daniel Faga holds 40.3 times base salary in stock. $28.47M of shares against $706.01K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Faga last reported holding, valued at $57.40, the price Common Stock was last bought or sold at on the open market here, on 30 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
EcoR1 Capital, LLC entity
Director
$97.56M (14)
$14.45M (1)
+$83.10M
15,400,518
52.92%
$883.97M
+35.9%
Novo Holdings A/S entity
10% owner
$750.00K (1)
$23.32M (9)
−$22.57M
1,936,604
6.65%
$111.16M
Suria Hamza
President, CEO
$15.75M (25) scheduled
−$15.75M
68,600
0.2357%
$3.94M
Faga Daniel
President, CEO
$6.34M (16)
−$6.34M
495,965
1.70%
$28.47M
+12,247%
Frazier Healthcare V, LP entity
10% owner
$6.00M (2)
+$6.00M
1,062,321
3.65%
$60.98M
Frazier Healthcare VII, L.P.
10% owner
$6.00M (2)
+$6.00M
1,284,903
4.42%
$73.75M
Topper James N
Director
$6.00M (2)
+$6.00M
980,512
3.37%
$56.28M
+736.4%
LOUMEAU ERIC J
CHIEF LEGAL OFFICER
$4.40M (26) scheduled
−$4.40M
12,835
0.0441%
$736.71K
+157.0%
Londei Marco
Chief Medical Officer
$4.07M (9) scheduled
−$4.07M
68,579
0.2357%
$3.94M
Piscitelli Dominic
Chief Financial Officer
$2.67M (6) scheduled
−$2.67M
0
0.0000%
$0.00
Lydon Nicholas
Director
$249.99K (1)
$2.87M (7)
−$2.62M
271,106
0.9316%
$15.56M
+302.6%
MULROY DENNIS
CHIEF FINANCIAL OFFICER
$2.31M (13) scheduled
−$2.31M
21,852
0.0751%
$1.25M
+474.3%
RENTON HOLLINGS
Director
$1.37M (9) scheduled
−$1.37M
10,995
0.0378%
$631.10K
Schmid John P.
Director
$1.16M (3)
−$1.16M
37,652
0.1294%
$2.16M
Avalon Ventures VII L P entity
10% owner
$901.92K (1)
−$901.92K
0
0.0000%
$0.00
−100.0%
Lizzul Paul F.
Chief Medical Officer
$895.16K (10)
−$895.16K
42,088
0.1446%
$2.42M
+808.2%
Marquet Magda
Director
$530.53K (2) scheduled
−$530.53K
9,930
0.0341%
$569.97K
Ware J. Anthony
Director
$50.58K (1)
$193.34K (1)
−$142.76K
9,630
0.0331%
$552.75K
FENTON DENNIS M
Director
$117.45K (2) scheduled
−$117.45K
4,965
0.0171%
$284.99K
Gallagher Carol Giltner
Director
64,296
0.2209%
$3.69M
Orwin John A
Director
17,995
0.0618%
$1.03M
Jain Rita
Director
11,864
0.0408%
$680.98K
Insider
Date
Role
Action
Shares
Price
Amount
LOUMEAU ERIC J
18 Dec 2025
CHIEF LEGAL OFFICER
Sold on a plan
141
$46.99
$6.63K
RENTON HOLLINGS
18 Jun 2025
Director
Sold on a plan
3,015
$23.97
$72.27K
FENTON DENNIS M
18 Jun 2025
Director
Sold on a plan
3,015
$23.97
$72.27K
LOUMEAU ERIC J
17 Sep 2024
CHIEF LEGAL OFFICER
Sold on a plan
3,780
$38.41
$145.19K
Lizzul Paul F.
16 Sep 2024
Chief Medical Officer
Sold on a plan
2,220
$38.93
$86.42K
FENTON DENNIS M
21 Jun 2024
Director
Sold on a plan
1,950
$23.17
$45.18K
MULROY DENNIS
22 May 2024
CHIEF FINANCIAL OFFICER
Sold on a plan
1,500
$23.72
$35.58K

What was left out

Form 4 filings counted 264
Amendments (4/A) skipped 1
Filings about a different issuer 1
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 67
Sales at will 66
Transactions with no price 0
Shares from compensation/vesting 22,373,949
Sales filed before the plan box existed 26
History held since 31 Jan 2017